NASDAQ:MBX MBX Biosciences Q2 2026 Earnings Results & Report $49.56 -2.46 (-4.72%) As of 02:00 PM Eastern This is a fair market value price provided by Massive. Learn more. MBX Biosciences missed analyst earnings expectations in its Q2 2026 results, released August 6, 2026. The company reported EPS of -$0.78 versus the -$0.68 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 6, 2026TimeBefore Market OpensConference Call8:00 AM ET MBX Biosciences EPS ResultsActual EPS-$0.78Consensus EPS -$0.68Beat/MissMissed by -$0.10One Year Ago EPSN/AEPS Beat Rate2 of last 4 quartersMBX Biosciences Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) MBX Biosciences Q2 2026 Earnings FAQ Did MBX Biosciences beat earnings estimates for Q2 2026? MBX Biosciences (NASDAQ:MBX) reported earnings of -$0.78 per share for Q2 2026, missing the consensus estimate of -$0.68. The report was announced on Thursday, August 6, 2026. MBX Biosciences Earnings HeadlinesMBX Biosciences to Participate in Upcoming November Investor ConferencesOctober 13 at 8:00 AM | globenewswire.comMBX Biosciences (NASDAQ:MBX) Stock Price Target Raised at Stifel NicolausOctober 12 at 8:07 AM | americanbankingnews.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.October 13 at 1:00 AM | Weiss Ratings (Ad)MBX Biosciences, Inc. (NASDAQ:MBX) Stock Has Consensus Target Price of $83.89 According to BrokeragesOctober 12 at 2:44 AM | americanbankingnews.comIs MBX Biosciences (MBX) Still Undervalued After Its Pullback From A Strong 1 Year Run?October 10 at 10:12 AM | finance.yahoo.comMBX Biosciences (MBX) Stock Could Be Above Fair Value As Shares Jumped 257%October 9, 2026 | finance.yahoo.comSee More MBX Biosciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like MBX Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MBX Biosciences and other key companies, straight to your email. Email Address About MBX BiosciencesMBX Biosciences (NASDAQ:MBX) is a clinical-stage biopharmaceutical company focused on developing peptide therapies for endocrine and metabolic disorders. The company uses its Precision Endocrine Peptide platform to design engineered peptides intended to provide targeted activity, extended duration and more consistent treatment effects. MBX’s lead program, MBX 1416, is an investigational long-acting parathyroid hormone receptor agonist being developed as a potential replacement therapy for people with hypoparathyroidism, a disorder in which the body produces insufficient parathyroid hormone. The company’s broader pipeline is focused on additional peptide-based medicines for endocrine diseases with significant unmet treatment needs. Headquartered in Indianapolis, Indiana, MBX Biosciences is advancing its programs through clinical development and regulatory evaluation. Its therapies are intended for patients in markets where endocrine disorders are treated with approved pharmaceutical products, although specific commercial geographies will depend on future clinical results and regulatory authorizations.View MBX Biosciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season NearsMarketBeat Week in Review – 10/05 - 10/09 Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
